Preventive Care in Nursing and Midwifery Journal
Zanjan University of Medical Science
Sun, May 19, 2024
[Archive]
Volume 11, Issue 4 (12-2021)
PCNM 2021, 11(4): 55-62 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khosravi A, Alavi M, Eghbali Babadi M, Shahriari M, Molavi R, Mahmoodi A et al . Physicians’ Perspectives of the Factors Influential in Implementing National Clinical Guidelines for Hypertension in Iran: A Qualitative Study. PCNM 2021; 11 (4) :55-62
URL: http://nmcjournal.zums.ac.ir/article-1-724-en.html
URL: http://nmcjournal.zums.ac.ir/article-1-724-en.html
Alireza Khosravi 
, Mousa Alavi * , Maryam Eghbali Babadi , Mohsen Shahriari , Razieh Molavi , Azam Mahmoodi , Mandy Archibald
, Mousa Alavi * , Maryam Eghbali Babadi , Mohsen Shahriari , Razieh Molavi , Azam Mahmoodi , Mandy Archibald
Ph.D, Associate Professor, Nursing and Midwifery Care Research Center, Isfahan university of Medical Sciences, Isfahan, Iran , m_alavi@nm.mui.ac.ir
Abstract: (4933 Views)
Background: Although clinical guidelines help in the prevention, diagnosis, and management of hypertension, individuals with hypertension often remain undiagnosed, or once diagnosed, may not receive adequate care and treatment.
Objectives: In this study, we explored physicians’ perspectives of the factors influential in implementing the Iranian Recommendations on Prevention, Evaluation, and Management of Hypertension (IRPEM-HTN).
Methods: A qualitative descriptive study was conducted using the purposeful sampling method to enroll 30 physicians from October 2016 to May 2018. The physicians working in private offices or university-affiliated health centers/hospitals in the province of Isfahan, Iran, were included in this study one year after participating in the IRPEM-HTN program. The data were gathered through semi-structured interv iews. The transcribed data were thematically analyzed, and the rigor was ensured following the procedure outlined by Braun and Clark.
Results:This themes identified were: 1) macro- and meso-contextual factors, emphasizing that a) policies at all levels affect guideline adherence, and b) environmental-contextual factors affect guideline adherence, 2) micro level factors, emphasizing that c) attributes of the guideline affect guideline adherence, and d) clinician- and patient-level factors affect guideline adherence. Micro-, meso- and macro-level factors influenced guideline implementation.
Conclusion: The attitudes, awareness, knowledge, and capacity of clinicians, as well as a broader socio-cultural context should be taken into account for guideline implementation.
Objectives: In this study, we explored physicians’ perspectives of the factors influential in implementing the Iranian Recommendations on Prevention, Evaluation, and Management of Hypertension (IRPEM-HTN).
Methods: A qualitative descriptive study was conducted using the purposeful sampling method to enroll 30 physicians from October 2016 to May 2018. The physicians working in private offices or university-affiliated health centers/hospitals in the province of Isfahan, Iran, were included in this study one year after participating in the IRPEM-HTN program. The data were gathered through semi-structured interv iews. The transcribed data were thematically analyzed, and the rigor was ensured following the procedure outlined by Braun and Clark.
Results:This themes identified were: 1) macro- and meso-contextual factors, emphasizing that a) policies at all levels affect guideline adherence, and b) environmental-contextual factors affect guideline adherence, 2) micro level factors, emphasizing that c) attributes of the guideline affect guideline adherence, and d) clinician- and patient-level factors affect guideline adherence. Micro-, meso- and macro-level factors influenced guideline implementation.
Conclusion: The attitudes, awareness, knowledge, and capacity of clinicians, as well as a broader socio-cultural context should be taken into account for guideline implementation.
Keywords: hypertension, preventive care, clinical practice guideline, facilitators, barriers, physicians
Type of Study: Orginal research |
Subject:
other
Received: 2021/02/17 | Accepted: 2021/12/1 | Published: 2021/12/1
Received: 2021/02/17 | Accepted: 2021/12/1 | Published: 2021/12/1
References
1. Park JB. Asian Guidelines on Hypertension. Pulse. 2015; 3(1): 12-13. [Crossref]
2. Chukwuma A, Gong E, Latypova M, Fraser-Hurt N. Challenges and opportunities in the continuity of care for hypertension: a mixed-methods study embedded in a primary health care intervention in Tajikistan. BMC health services research. 2019; 19(1): 1-3. [Crossref]
3. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of Hypertension in Iran 1980-2012: A Systematic Review. J Tehran Heart Cent. 2016; 11(4): 159-67.
4. Field MJ, Lohr KN, Guidelines CAPHSCP, Medicine I. Clinical Practice Guidelines: Directions for a New Program. Washington: National Academies Press; 1990. [Crossref]
5. Eccles M, Grimshaw J, Irvine D. Clinical Guidelines from Conception to Use. England: Radcliffe Medical Press; 2000.
6. Umanath, K. Hypertension: A Common but Complex Condition. Adv Chronic Kidney Dis, 2019; 26(2): 85-86. [Crossref]
7. Mancia G, Dominiczak A. The new International Society of Hypertension guidelines on hypertension. J Hypertens. 2020; 38(6): 981. [Crossref]
8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31(7): 1281-357. [Crossref]
9. McManus RJ, Caulfield M, Williams B. NICE hypertension guideline 2011: evidence based evolution. BMJ. 2012; 344: e181. [Crossref]
10. Noohi F, Sarrafzadegan N, Khosravi A, Andalib E. The first Iranian recommendations on prevention, evaluation and management of high blood pressure. ARYA atherosclerosis. 2012; 8(3): 97-118.
11. Bhattacharyya OK, Estey EA, Zwarenstein M. Methodologies to evaluate the effectiveness of knowledge translation interventions: a primer for researchers and health care managers. Journal of clinical epidemiology. 2011; 64(1): 32-40. [Crossref]
12. Lin N, Martins SB, Chan A, Coleman RW, Bosworth H, Oddone E, et al., editors. Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care. AMIA Annu Symp Proc. 2006; 2006: 494-98.
13. Midlöv P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, et al. Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey. Scand J Prim Health Care. 2008; 26(3):154-59. [Crossref]
14. Al-Ali KA, Al-Ghanim FA, Al-Furaih AM, Al-Otaibi N, Makboul G, El-Shazly MK. Awareness of hypertension guidelines among family physicians in primary health care. Alexandria Med J. 2013; 49(1): 81-7. [Crossref]
15. Wang L. Physician-related barriers to hypertension management. Medical Principles and Practice. 2004; 13(5): 282-5. [Crossref]
16. Unger, T, Borghi, C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020; 75(6), 1334-57. [Crossref]
17. Powell-Cope GM, Luther S, Neugaard B, Vara J, Nelson A. Provider-perceived barriers and facilitators for ischaemic heart disease (IHD) guideline adherence. J Eval Clin Pract. 2004; 10(2): 227-39. [Crossref]
18. Odusola AO, Stronks K, Hendriks ME, Schultsz C, Akande T, Osibogun A, et al. Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers. Glob Health Action. 2016; 9(1): 29041. [Crossref]
19. Hennink M, Hutter I, Bailey A. Qualitative Research Methods. London: Sage Pub; 2020.
20. Elo S, Kääriäinen M, Kanste O, Pölkki T, Utriainen K, Kyngäs H. Qualitative Content Analysis:A Focus on Trustworthiness. SAGE Open. 2014; 4(1): 2158244014522633. [Crossref]
21. Van Rijnsoever FJ. (I Can't Get No) Saturation: A simulation and guidelines for sample sizes in qualitative research. PloS one. 2017; 12(7): e0181689. [Crossref]
22. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006; 3(2): 77-101. [Crossref]
23. Lee PY, Liew SM, Abdullah A, Abdullah N, Ng CJ, Hanafi NS, et al. Healthcare professionals' and policy makers' views on implementing a clinical practice guideline of hypertension management: a qualitative study. PloS one. 2015; 10(5): e0126191. [Crossref]
24. Donnellan C, Sweetman S, Shelley E. Implementing clinical guidelines in stroke: a qualitative study of perceived facilitators and barriers. Health Policy. 2013; 111(3): 234-44. [Crossref]
25. Sarrafzadegan N, Rabiei K, Alavi M, Abedi H, Zarfeshani S. How can the results of a qualitative process evaluation be applied in management, improvement and modification of a preventive community trial? The IHHP Study. Archives Public Health. 2011; 69(1): 9. [Crossref]
26. Vest BM, York TR, Sand J, Fox CH, Kahn LS. Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD Study. J Am Board Fam Med. 2015; 28(5): 624-31. [Crossref]
27. Sigmund CD, Carey RM, Appel LJ, Arnett DK, Bosworth HB, Cushman WC, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation. Hypertension. 2020; 75(4): 902-17. [Crossref]
28. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014; 17(5): 304-20.
29. Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016; 4(3): 36. [Crossref]
30. Mosavianpour M, Collett J, Sarmast H, Kissoon N. Barriers to the implementation of sepsis guideline in a Canadian pediatric tertiary care centre. J Nurs Educ Pract. 2016; 6(12): 34-40. [Crossref]
31. Hisham R, Ng CJ, Liew SM, Hamzah N, Ho GJ. Why is there variation in the practice of evidence-based medicine in primary care? A qualitative study. BMJ open. 2016; 6(3): e010565. [Crossref]
32. Dugelay G, Kivits J, Desse L, Boivin JM. Implementation of home blood pressure monitoring among French GPs: A long and winding road. PloS one. 2019; 14(9): e0220460. [Crossref]
33. Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PloS one. 2014; 9(1): e84238. [Crossref]
34. Alavi M, Irajpour A, Giles T, Rabiei K, Sarrafzadegan N. Barriers to education in cardiac rehabilitation within an Iranian society: a qualitative descriptive study. Contemp Nurse. 2013; 44(2): 204-14. [Crossref]
35. Khan N, Bacon SL, Khan S, Perlmutter S, Gerlinsky C, Dermer M, et al. Hypertension management research priorities from patients, caregivers, and healthcare providers: A report from the Hypertension Canada Priority Setting Partnership Group. J clin hypertens (Greenwich). 2017; 19(11): 1063-9. [Crossref]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
